 |
 |
 |
|
|
|
|
|
|
|
|
||
|
|
|
|
||||||||||||||
|
|
||||||||||||||
|
|||||||||||||||
|
|
||||||||||||||
|
|
|
|
|
Partnerships |
|
Galenea has partnered its calcineurin program with Otsuka Phamaceuticals. For more information see our
Investors page. Beyond this initial program, Galenea seeks to develop additional late discovery (with identified leads) or pre-clinical stage products with a primary focus on licensing or acquiring candidates that may prove effective in the treatment of neurologic and psychiatric disorders.
|
|
|
Next Science & Technology »
|
|
|
|||
|
|||
|